These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 11078417

  • 1. Endothelin-receptor antagonists in uremic cardiomyopathy.
    Wolf SC, Gaschler F, Brehm S, Klaussner M, Amann K, Risler T, Brehm BR.
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S348-50. PubMed ID: 11078417
    [Abstract] [Full Text] [Related]

  • 2. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy.
    Wolf SC, Amend T, Risler T, Amann K, Brehm BR.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():276S-279S. PubMed ID: 12193103
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of endothelin antagonists in chronic renal failure.
    Wolf SC, Brehm BR, Gaschler F, Brehm S, Klaussner M, Smykowski J, Amann K, Osswald H, Erley CM, Risler T.
    Nephrol Dial Transplant; 1999 Aug; 14 Suppl 4():29-30. PubMed ID: 10463205
    [Abstract] [Full Text] [Related]

  • 4. Influence of endothelin receptor antagonism on smooth muscle cell proliferation after chronic renal failure.
    Sauter G, Wolf S, Risler T, Brehm B.
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S165-7. PubMed ID: 15838271
    [Abstract] [Full Text] [Related]

  • 5. Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.
    Nabokov AV, Amann K, Wessels S, Münter K, Wagner J, Ritz E.
    Kidney Int; 1999 Feb; 55(2):512-9. PubMed ID: 9987075
    [Abstract] [Full Text] [Related]

  • 6. Remodeling of resistance arteries in renal failure: effect of endothelin receptor blockade.
    Amann K, Mil Tenberger-Mil Tenyi G, Simonoviciene A, Koch A, Orth S, Ritz E.
    J Am Soc Nephrol; 2001 Oct; 12(10):2040-2050. PubMed ID: 11562402
    [Abstract] [Full Text] [Related]

  • 7. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Brochu E, Lacasse S, Moreau C, Lebel M, Kingma I, Grose JH, Larivière R.
    Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
    [Abstract] [Full Text] [Related]

  • 8. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats.
    Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P.
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):428-37. PubMed ID: 11026642
    [Abstract] [Full Text] [Related]

  • 9. Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism.
    Wolf SC, Sauter G, Rodemann HP, Risler T, Brehm BR.
    Nephrol Dial Transplant; 2005 Feb; 20(2):312-8. PubMed ID: 15585510
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.
    Brochu E, Lacasse S, Larivière R, Kingma I, Grose JH, Lebel M.
    J Am Soc Nephrol; 1999 Jul; 10(7):1440-6. PubMed ID: 10405199
    [Abstract] [Full Text] [Related]

  • 11. Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals.
    Amann K, Münter K, Wessels S, Wagner J, Balajew V, Hergenröder S, Mall G, Ritz E.
    J Am Soc Nephrol; 2000 Sep; 11(9):1702-1711. PubMed ID: 10966495
    [Abstract] [Full Text] [Related]

  • 12. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K, Gassmann P, Buzello M, Orth SR, Törnig J, Gross ML, Magener A, Mall G, Ritz E.
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [Abstract] [Full Text] [Related]

  • 13. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
    Yamauchi-Kohno R, Miyauchi T, Hoshino T, Kobayashi T, Aihara H, Sakai S, Yabana H, Goto K, Sugishita Y, Murata S.
    Circulation; 1999 Apr 27; 99(16):2171-6. PubMed ID: 10217659
    [Abstract] [Full Text] [Related]

  • 14. Chronic exposure to carbon monoxide and nicotine: endothelin ET(A) receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat.
    Loennechen JP, Nilsen OG, Arbo I, Aadahl P, Nilsen T, Waldum HL, Sandvik AK, Ellingsen O.
    Toxicol Appl Pharmacol; 2002 Jan 01; 178(1):8-14. PubMed ID: 11781074
    [Abstract] [Full Text] [Related]

  • 15. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats.
    Wolf SC, Sauter G, Risler T, Brehm BR.
    Ren Fail; 2005 Jan 01; 27(4):465-74. PubMed ID: 16060137
    [Abstract] [Full Text] [Related]

  • 16. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B, Winaver J, Karram T, Hoffman A, Abassi Z.
    J Cardiovasc Pharmacol; 2004 Nov 01; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [Abstract] [Full Text] [Related]

  • 17. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats.
    Shimizu T, Hata S, Kuroda T, Mihara S, Fujimoto M.
    Eur J Pharmacol; 1999 Sep 17; 381(1):39-49. PubMed ID: 10528132
    [Abstract] [Full Text] [Related]

  • 18. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P, Richard V, Derumeaux G, Hogie M, Henry JP, Lallemand F, Compagnon P, Macé B, Comoy E, Letac B, Thuillez C.
    Circulation; 1997 Sep 16; 96(6):1976-82. PubMed ID: 9323089
    [Abstract] [Full Text] [Related]

  • 19. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A, Amann K, Wagner J, Gehlen F, Münter K, Ritz E.
    Nephrol Dial Transplant; 1996 Mar 16; 11(3):514-20. PubMed ID: 8671823
    [Abstract] [Full Text] [Related]

  • 20. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J, Priem F, Bauer C, Neumayer HH, Raschak M, Hocher B.
    Clin Sci (Lond); 2002 Aug 16; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.